Interstitial lung diseases and COVID?19

Basit Öğe Kaydı
dc.authorid
dc.contributor.authorGülhan, Pınar Yıldız
dc.contributor.authorDemirci, Nilgun Yilmaz
dc.contributor.authorBozkus, Fulsen
dc.contributor.authorYazıcı, Onur
dc.contributor.authorCoskun, Funda
dc.date.accessioned2021-12-01T18:22:52Z
dc.date.available2021-12-01T18:22:52Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractThere is continued lack of knowledge of the physiopathology and recovery processes of the newcoronavirus pneumonia. The complications are similar to those experienced with severe acuterespiratory syndrome and Middle East respiratory syndrome, since the new coronavirus is part ofthe same family. The new coronavirus infects both the epithelial cells of the airway and also alveolarepithelial cells (Type I and Type II pneumocyte). The Type I and Type II pneumocytes infected withthe human coronavirus (hCoV) play a critical role in mediating the lung pathology and host sensitivity.Both human and animal studies have demonstrated that an inflammatory process starts in the lungsfollowing hCoV infection and that an accumulation of monocyte–macrophage and neutrophils occurs.One of the earliest outcomes of rapid virus replication and increased proinflammatory cytokine/chemokine response is apoptosis of the epithelial and endothelial cells of the lung. The main effectof the new coronavirus on the body is an imbalance in the ratio of the cytokines produced by thebody in response to the abnormal immune reaction, resulting from the invasion of the virus. Thismanuscript details the pathophysiology of the new coronavirus associated with fibrosis and makesrecommendations for cases with interstitial lung disease.en_US
dc.identifier.doi10.4103/ejop.ejop_46_20
dc.identifier.endpage66en_US
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue1en_US
dc.identifier.startpage61en_US
dc.identifier.urihttps://doi.org/10.4103/ejop.ejop_46_20
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpnNE9EazNOdz09
dc.identifier.urihttps://hdl.handle.net/20.500.12684/9584
dc.identifier.volume22en_US
dc.identifier.wosWOS:000578603800013en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.relation.ispartofEurasian Journal of Pulmonologyen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleInterstitial lung diseases and COVID?19en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
9584.pdf
Boyut:
815.78 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu